MediQuest Therapeutics Inc.
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From MediQuest Therapeutics Inc.
MediQuest receives FDA response for Raynaud's drug
The US FDA has told MediQuest Therapeutics that its NDA for its lead candidate, Vascana (MQX-503) – a potential topical therapy for Raynaud's disease, cannot be approved in its present form.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Topical Delivery
-
Drug Delivery
- Other Names / Subsidiaries
-
- MQT Holdings LLC
- MediQuest Holdings LLC
- Origen Corp
- Oridigm Corp.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MediQuest Therapeutics Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice